Nahúm Méndez‐Sánchez

ORCID: 0000-0001-5257-8048 · 1 paper in corpus

nonrandomized-trial 2011

Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin

Annals of hepatology ·doi:10.1016/s1665-2681(19)31513-3

BACKGROUND: Thrombocytopenia is a common hematologic disorder observed in patients with chronic hepatitis C virus (HCV) infection. Combined peginterferon (PEG-INF) and ribavirin treatment may exacerbate thrombocytopenia in patients with HCV…